Operating CRISPR/Cas12a in a complex nucleic acid sequence background
Nucleic Acids Research · 23.04.2026 · 54 (8)
DOI: 10.1093/nar/gkag390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 30.04.2026. Verfasst von Henning Hellmer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience, School of Natural Sciences, Technical University of Munich, Garching, D-85748, Germany. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, CRISPR-Associated Proteins, RNA, Guide, CRISPR-Cas Systems, Endodeoxyribonucleases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Since their discovery, CRISPR-Cas systems have been widely applied in areas ranging from genome editing to biosensing, owing to their specific, RNA-guided target recognition. Their performance in complex biological environments has been extensively studied, particularly to optimize guide RNA (gRNA) design and minimize off-target cleavage. Here, we focus on the kinetic inhibition of the interaction between Cas12a—a Class 2, Type V effector—and its target, caused by interference from non-cognate background nucleic acids. This effect is particularly relevant for sensing applications in complex mixtures or cellular contexts, where genome- and transcriptome-derived sequences may impede CRISPR-Cas activity. Using in vitro assays under defined conditions, we systematically examine the influence of background single-stranded RNA and double-stranded DNA (dsDNA) on reaction kinetics. We find that both the purine-to-pyrimidine ratio and the GC content of the gRNA seed region significantly affect kinetic inhibition by background polynucleotides. gRNAs with low GC content and a high purine fraction in the seed region were least affected by background sequences. A gRNA with high uracil content in the seed region exhibited particularly strong inhibition in the presence of a dsDNA background. Experiments with dCas12a-based gene activation in living cells indicate that our in vitro findings may also be relevant for in vivo applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bioscience, School of Natural Sciences, Technical University of Munich, Garching, D-85748, Germany.
ORCID-Profile: Henning Hellmer, Thomas Mayer, Lea Bauersachs, Friedrich C Simmel
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Hellmer, H., Mayer, T., Bauersachs, L., & Simmel, F. C. (2026). Operating CRISPR/Cas12a in a complex nucleic acid sequence background. Nucleic Acids Research, 54(8). https://doi.org/10.1093/nar/gkag390
Vancouver
Hellmer H, Mayer T, Bauersachs L, Simmel FC. Operating CRISPR/Cas12a in a complex nucleic acid sequence background. Nucleic Acids Research. 2026;54(8). doi:10.1093/nar/gkag390
BibTeX
@article{Hellmer2026,
author = {Hellmer, Henning and Mayer, Thomas and Bauersachs, Lea and Simmel, Friedrich C},
title = {Operating CRISPR/Cas12a in a complex nucleic acid sequence background},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {8},
doi = {10.1093/nar/gkag390}
}
EUVIMED